Mild Cognitive Impairment due to Alzheimer's Disease
Showing 1 - 25 of >10,000
Alzheimer's Disease (AD) Trial (SHR-1707 injection)
Not yet recruiting
- Alzheimer's Disease (AD)
- SHR-1707 injection
- (no location specified)
Nov 2, 2023
Mild Cognitive Impairment, Prodromal Alzheimer's Disease Trial (AGB101, Placebo)
Not yet recruiting
- Mild Cognitive Impairment
- Prodromal Alzheimer's Disease
- AGB101
- Placebo
- (no location specified)
Aug 3, 2023
Alzheimer Trial (low intensity focused ultrasound (LIFU))
Not yet recruiting
- Alzheimer Disease
- low intensity focused ultrasound (LIFU)
- (no location specified)
Aug 10, 2023
Mild Cognitive Impairment, Mild Dementia, Alzheimer's Disease Trial in United States (SAGE-718, SAGE-718-matching Placebo)
Recruiting
- Mild Cognitive Impairment
- +2 more
- SAGE-718
- SAGE-718-matching Placebo
-
Redlands, California
- +3 more
Jan 13, 2023
Mild Cognitive Impairment, Mild Dementia, Moderate Dementia Trial in Charlestown (Biological/Vaccine: Bacillus Calmette-Guerin
Active, not recruiting
- Mild Cognitive Impairment
- +3 more
- Biological/Vaccine: Bacillus Calmette-Guerin (BCG)
-
Charlestown, MassachusettsAlzheimer's Clinical and Translational Research Unit
Feb 2, 2023
Alzheimer's Disease, Mild Cognitive Impairment Trial in Irvine, Los Angeles (Nicotinamide, Placebo Comparator)
Completed
- Alzheimer's Disease
- Mild Cognitive Impairment
- Nicotinamide
- Placebo Comparator
-
Irvine, California
- +1 more
Dec 14, 2022
Alzheimer's Disease Trial (SHR-1707, SHR-1707 )
Not yet recruiting
- Alzheimer's Disease
- SHR-1707
- SHR-1707 placebo
- (no location specified)
Jan 4, 2023
Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia Trial in Maitland, Spokane (BIIB080,
Recruiting
- Mild Cognitive Impairment Due to Alzheimer's Disease
- Alzheimer's Disease Dementia
- BIIB080
- BIIB080-matching placebo
-
Lady Lake, Florida
- +5 more
Jan 20, 2023
Mild Cognitive Impairment (MCI) or Mild Dementia Due to Alzheimer's Disease Trial in Downey (FitMi AD, Conventional exercise
Not yet recruiting
- Mild Cognitive Impairment (MCI) or Mild Dementia Due to Alzheimer's Disease
- FitMi AD
- Conventional exercise program
-
Downey, CaliforniaRancho Research Institute, Inc
Aug 15, 2022
Tool in Mild and Major Neurocognitive Disorder Predominantly Due
Recruiting
- Dementia Alzheimers
- +3 more
- CogCheck
-
Basel, BS, SwitzerlandMemory Clinic, University Department of Geriatric Medicine FELIX
Nov 1, 2022
Medicare Anti-Aß mAb Coverage With Evidence Development Study
Recruiting
- Mild Alzheimer's Disease
- Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
- Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
-
Baltimore, MarylandCenters for Medicare and Medicaid Services
Sep 21, 2023
Biomarkers of Cognitive Impairment in Blood Cells
Recruiting
- Mild Cognitive Impairment Due to Alzheimer's Disease
- Dementia Due to Alzheimer's Disease (Disorder)
- No intervention will be performed.
-
Palma, Mallorca, Balearic Islands, SpainUniversity of the Balearic Islands
Oct 19, 2022
Turkish Speech Analysis Development Study
Enrolling by invitation
- Alzheimer Disease
- Mild Cognitive Impairment
-
Ankara, Cankaya, TurkeyAnkara university Faculty of medicine
Feb 16, 2023
Brain Stimulation, Alzheimer, tACS Trial in Hong Kong (High-definition transcranial current stimulation)
Enrolling by invitation
- Brain Stimulation
- +5 more
- High-definition transcranial current stimulation
-
Hong Kong, Hong KongThe Chinese University of Hong Kong
Sep 14, 2022
Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)
Recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
- Canakinumab
- Placebo
-
Charlestown, Massachusetts
- +11 more
Nov 11, 2022
Mild Cognitive Impairment, Dementia Trial in United States (CST-2032, matching for CST-2032, CST-107, matching for CST-107)
Recruiting
- Mild Cognitive Impairment
- Dementia
- CST-2032, matching placebo for CST-2032, CST-107, matching placebo for CST-107
-
Scottsdale, Arizona
- +14 more
Jan 4, 2023
Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease, Healthy Volunteers Trial in Wuhan ([18F]APN-1607)
Recruiting
- Alzheimer's Disease
- +2 more
-
Wuhan, Hubei, ChinaUnion Hospital Tongji Medical College Huazhong University of Sci
Sep 13, 2022
Early Alzheimers Disease, Mild Cognitive Impairment Due to AD Trial in Worldwide (PQ912, Placebo)
Active, not recruiting
- Early Alzheimers Disease
- Mild Cognitive Impairment Due to AD
- PQ912
- Placebo
-
Ganderup, Denmark
- +20 more
Dec 23, 2022
Cognitive Impairment, Mild, Cognitive Dysfunction, Amyloid Plaque Trial in Phoenix, Las Vegas (Lenalidomide 10 mg, Placebo)
Recruiting
- Cognitive Impairment, Mild
- +4 more
- Lenalidomide 10 mg
- Placebo
-
Phoenix, Arizona
- +1 more
Apr 14, 2022
Mild Cognitive Impairment, Chronic Inflammation Trial (grounding mat)
Not yet recruiting
- Mild Cognitive Impairment
- Chronic Inflammation
- grounding mat
- (no location specified)
Sep 20, 2021
Mild Cognitive Impairment Due to Alzheimer's Disease Trial in Berlin (Contraloid acetate, Placebo)
Recruiting
- Mild Cognitive Impairment Due to Alzheimer's Disease
- Contraloid acetate
- Placebo
-
Berlin, GermanyCharité University Medicine
Apr 20, 2021